These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19526965)

  • 1. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
    Jenh AM; Pham PA
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1079-92. PubMed ID: 20954872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Reijnders JG; Janssen HL
    J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic hepatitis B. Tenofovir--the right choice from the beginning].
    MMW Fortschr Med; 2008 May; 150(21):42-3. PubMed ID: 18575255
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
    Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
    Liu Y; Wang CM; Cheng J; Liang ZL; Zhong YW; Ren XQ; Xu ZH; Zoulim F; Xu DP
    Chin Med J (Engl); 2009 Jul; 122(13):1585-6. PubMed ID: 19719953
    [No Abstract]   [Full Text] [Related]  

  • 7. Europe extends Viread indication for chronic hepatitis B.
    AIDS Patient Care STDS; 2008 Apr; 22(4):350. PubMed ID: 18434949
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenofovir for the treatment of hepatitis B virus.
    Jenh AM; Thio CL; Pham PA
    Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
    Bronowicki JP; Barraud H; Couzigou P
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
    [No Abstract]   [Full Text] [Related]  

  • 10. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
    Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
    Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir salvage for nucleoside experienced patients: muddy waters?
    Mutimer D
    Gut; 2011 Feb; 60(2):148-50. PubMed ID: 21205876
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Van Bömmel F; Schernick A; Hopf U; Berg T
    Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.
    Carosi G; Rizzetto M; Alberti A; Cariti G; Colombo M; Craxì A; Filice G; Levrero M; Mazzotta F; Pastore G; Piccinino F; Prati D; Raimondo G; Sagnelli E; Toti M; Brunetto M; Bruno R; Di Marco V; Ferrari C; Gaeta GB; Lampertico P; Marzano A; Pollicino T; Puoti M; Santantonio T; Smedile A
    Dig Liver Dis; 2011 Apr; 43(4):259-65. PubMed ID: 21276760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
    Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
    Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V; Craxì A
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis B: update 2009.
    Lok AS; McMahon BJ
    Hepatology; 2009 Sep; 50(3):661-2. PubMed ID: 19714720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Marcellin P; Lada O
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
    [No Abstract]   [Full Text] [Related]  

  • 20. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.